Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and ...

BridgeBio Pharma Inc. jumped the most in 16 months after its drug got US regulators’ nod to treat a rare, deadly form of ...

Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for adults with ATTR-CM ...

Researchers have developed a breakthrough system to deliver large therapeutic molecules into the brain, overcoming the challenges of the blood-brain barrier.

Patents for plant-based meat declined for the first time in a decade in 2022, while innovation in cultivated meat slowed too.

Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach—demonstrated in mouse models ...

A research team at European XFEL and DESY has achieved a major advance in X-ray science by generating unprecedented ...

Awareness about haemochromatosis - a genetic condition that also affects people from Scotland, Wales, England, and Brittany - ...

Amylyx is progressing promising treatments for Wolfram Syndrome and Progressive Supranuclear Palsy with potential phase 3 trials. Learn more on AMLX stock here.

Amidst the wide variety of glycan modifications that are carried out in the Golgi apparatus, the addition of mannose 6-phosphate (M6P) to the N-linked glycans of lysosome-resident hydrolase enzymes ...

In line with the proposal for amending the warning statement of Insulin Lispro Ultrarapid Injection 100 IU & 200 IU, the ...

Transport for London, which blocks promotions for high-sugar foods as harmful, appears to have approved the poster campaign ...